New drug tested to stop breast Cancer's return
NCT ID NCT00877500
Summary
This study is for people with a type of breast cancer (HER2-negative) that did not completely disappear after standard chemotherapy before surgery. It tests whether adding a drug called ixabepilone after surgery helps control the cancer better than standard follow-up care alone. About 116 participants will be randomly assigned to receive either ixabepilone infusions or standard observation, and researchers will track if the cancer returns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453-2699, United States
-
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.